Search results
Sanofi Raises 2024 Profit Outlook On Strong Q2 Earnings, Blockbuster Drug Dupixent Sees Strong...
Benzinga via Yahoo Singapore Finance· 1 day agoOn Thursday, Sanofi SA (NASDAQ:SNY) reported a second-quarter business operating income of 2.8...
Sanofi lifts 2024 profit forecast on strength in Dupixent, new products
Reuters via Yahoo Singapore Finance· 1 day ago(Reuters) -Sanofi on Thursday raised its full-year profit outlook after strong demand for...
Sanofi lifts FY guidance after strong Q2 results
Investing.com via Yahoo Singapore Finance· 1 day agoInvesting.com - Sanofi (NASDAQ:SNY) stock rose Thursday after the French drugmaker lifted its full-year profit forecast after strong second-quarter results, based on strong ...
Sanofi: Q2 Earnings Snapshot
Associated Press Finance via Yahoo Singapore Finance· 1 day agoPARIS (AP) — PARIS (AP) — Sanofi (SNY) on Thursday reported second-quarter earnings of $1.2 billion. On a per-share basis, the company said it had profit of 48 cents. Earnings ...
Merck Competes With Sanofi/AstraZeneca As Its RSV Treatment Drug Meets Primary Goal In Late-Stage...
Benzinga via Yahoo Singapore Finance· 3 days agoOn Tuesday, Merck & Co Inc (NYSE:MRK) shared topline results from its Phase 2b/3 clinical trial...
Analysis-Drug giants eye China for deals despite growing Sino-US tensions
Reuters via Yahoo Singapore Finance· 4 days agoBristol Myers Squibb and Sanofi are also hunting for deals, according to company employees, even as...
Morning Bid: Stock rout spreads beyond tech
Reuters via Yahoo Singapore Finance· 1 day agoThe global equity sell-off looks set to extend into Europe on Thursday although the region may be spared the carnage in parts of Asia, where Japan's...
Roche lifts 2024 profit guidance on strong drug sales
Reuters via Yahoo Singapore Finance· 1 day agoFRANKFURT (Reuters) -Roche on Thursday raised its full-year earnings forecast after exceeding...
European shares fall as earnings deluge disappoints
Reuters via Yahoo Singapore Finance· 1 day agoSwiss contract drug manufacturer Lonza gained 7.1% after reporting a smaller-than-expected decline in first-half profit, while Sanofi jumped 4.2% after...
The global M&A market’s big-deal bravado is losing steam as rates stay high in 2024
Fortune via Yahoo Singapore Finance· 3 days agoHowever, some of this year’s transactions fell apart at the first hurdle, as shareholders started to...